Alyeska Investment Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-949,484
Closed -$94.3M 544
2019
Q3
$94.3M Hold
949,484
1.36% 8
2019
Q2
$87.8M Sell
949,484
-37,314
-4% -$3.54M 1.13% 16
2019
Q1
$93.1M Buy
+986,798
New +$86.3M 1.23% 13
2016
Q2
Sell
-1,474,752
Closed -$148M 553
2016
Q1
$148M Buy
1,474,752
+570,764
+63% +$58.8M 1.36% 3
2015
Q4
$108M Buy
+903,988
New +$105M 1.15% 7

Other funds holding CELG

Alyeska Investment Group's CELG Position: Q4 2019 in Review

Alyeska Investment Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 949,484 shares — an estimated $94.3M sold.

Alyeska Investment Group first reported a position in CELG in Q4 2015 and held it in 5 quarters. The position peaked at $148M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Alyeska Investment Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 949,484 Celgene Corp shares in Q4 2019, an estimated $94.3M.
  • Alyeska Investment Group first reported a position in Celgene Corp in Q4 2015 and held it in 5 quarters.
  • Alyeska Investment Group's Celgene Corp position peaked at $148M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.